Validation of the five‐drug “Pittsburgh cocktail” approach for assessment of selective regulation of drug‐metabolizing enzymes

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Clinical pharmacology and therapy

• Publication date

  1997-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0009-9236(97)90114-4PMID 9357387
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteine

  2004cited by this paper
• Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide

  2004cited by this paper
• [Comparison of serum concentrations of caffeine, 4-methylaminoantipyrine, sulfamethazine and debrisoquin following oral administration of these substances as a cocktail in type II diabetics before and after insulin therapy].

  1996cited by this paper
• Influence of Diet and Nutritional Status on Drug Metabolism

  1996cited by this paper
• Lack of pharmacokinetic interaction between dextromethorphan, coumarin and mephenytoin in man after simultaneous administration.

  1996cited by this paper
• Improved high-performance liquid chromatographic determination of debrisoquine and 4-hydroxydebrisoquine in human urine following direct injection.

  1996cited by this paper
• Influence of renal failure on cytochrome P450 activity in hypertensive patients using a “cocktail” of antipyrine and nifedipine

  1996cited by this paper
• Determination of chlorzoxazone and 6-hydroxychlorzoxazone in human plasma and urine by high-performance liquid chromatography.

  1996cited by this paper
• Vergleich der Serumkonzentration von Coffein, 4-Monomethylaminoantipyrin, Sulfamethazin and Debrisoquin nach oraler Verabreichung dieser Substanzen als Coktail bei Typ-II-Diabetikern vor und nach Umstellung auf Insulin

  1996cited by this paper
• N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity.

  1995cited by this paper
• The procarcinogen hypothesis for bladder cancer: activities of individual drug metabolizing enzymes as risk factors.

  1995cited by this paper
• Interaction between two probes used for phenotyping cytochromes P4501A2 (caffeine) and P4502E1 (chlorzoxazone) in humans.

  1995cited by this paper
• Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo

  1995cited by this paper
• Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.

  1994cited by this paper
• Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics.

  1994cited by this paper
• Assessment of Liver Metabolic Function

  1994cited by this paper
• Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism.

  1994cited by this paper
• Dapsone N‐acetylation, metoprolol α‐hydroxylation, and S‐mephenytoin 4‐hydroxylation polymorphisms in an Indonesian population: A cocktail and extended phenotyping assessment trial

  1994cited by this paper
• Frequency distribution of dapsone N‐hydroxylase, a putative probe for P4503A4 activity, in a white population

  1994cited by this paper
• Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancer.

  1994cited by this paper
• Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

  1994cited by this paper
• Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis.

  1994cited by this paper
• Effects of interferon-alpha monotherapy on hepatic drug metabolism in cancer patients.

  1993cited by this paper
• Pharmacokinetics of chlorzoxazone An in vivo probe of cytochrome P4502E1 activity

  1993cited by this paper
• The Relationship between Phenazone (Antipyrine) Metabolite Formation and Theophylline Metabolism in Healthy and Frail Elderly Women

  1993cited by this paper
• High-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in serum: a tool for indirect evaluation of cytochrome P4502E1 activity in humans.

  1993cited by this paper
• Cocktail Strategy: Complications and Limitations

  1993cited by this paper
• Comparison of hepatic drug-oxidizing activity after simultaneous administration of two probe drugs, caffeine and trimethadione, to human subjects.

  1993cited by this paper
• Single‐dose disulfiram inhibition of chlorzoxazone metabolism: A clinical probe for P450 2E1

  1993cited by this paper
• A simple useful method for the determination of hepatic function in patients with liver cirrhosis using caffeine and its three major dimethylmetabolites.

  1992cited by this paper
• The ability to 4-hydroxylate debrisoquine is related to recurrence of bladder cancer.

  1992cited by this paper
• Activity of oxidative routes of metabolism of debrisoquin, mephenytoin, and dapsone is unrelated to the pathogenesis of vinyl chloride–induced disease

  1992cited by this paper
• The disposition of dapsone in cirrhosis

  1992cited by this paper
• Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4.

  1992cited by this paper
• Lack of pharmacokinetic interaction between nifedipine, sparteine and phenytoin in man.

  1991cited by this paper
• Cytochrome P-450 : multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms

  1991cited by this paper
• Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1.

  1991cited by this paper
• Differential effects of quinidine on the disposition of nifedipine, sparteine, and mephenytoin in humans

  1991cited by this paper
• Metronidazole and antipyrine as probes for the study of foreign compound metabolism.

  1990cited by this paper
• Scleroderma is associated with differences in individual routes of drug metabolism: A study with dapsone, debrisoquin, and mephenytoin

  1990cited by this paper
• [Simultaneous administration of various model substances for characterizing in vivo biotransformation in chronic liver diseases].

  1990cited by this paper
• The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms.

  1990cited by this paper
• A 'cocktail' strategy to assess in vivo oxidative drug metabolism in humans.

  1990cited by this paper
• The contribution of N‐hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects

  1990cited by this paper
• Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism.

  1990cited by this paper
• Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1

  1990cited by this paper
• Effects of ketoconazole on the polymorphic 4-hydroxylations of S-mephenytoin and debrisoquine.

  1989cited by this paper
• Genetic polymorphism of S-mephenytoin hydroxylation.

  1989cited by this paper
• Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.

  1989cited by this paper
• Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a ‘cocktail’ approach

  1989cited by this paper
• Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin‐oxidation and N‐acetylation phenotypes in children

  1989cited by this paper
• S‐mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin

  1989cited by this paper
• Influence of enzyme induction and inhibition on the oxidation of nifedipine, sparteine, mephenytoin and antipyrine in humans as assessed by a "cocktail" study design.

  1989cited by this paper
• Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach.

  1988cited by this paper
• Simplified Phenotyping with Dextromethorphan by Thin‐Layer Chromatography: Application to Clinical Laboratory Screening for Deficiencies in Oxidative Drug Metabolism

  1988cited by this paper
• Metronidazole clearance: A one‐sample method and influencing factors

  1988cited by this paper
• Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors.

  1987cited by this paper
• Quinidine: potent inhibition of sparteine and debrisoquine oxidation in vivo.

  1986cited by this paper
• Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state.

  1985cited by this paper
• Mephenytoin hydroxylation deficiency in Caucasians: Frequency of a new oxidative drug metabolism polymorphism

  1984cited by this paper
• Interindividual Variations in Drug Disposition

  1983cited by this paper
• Intraindividual variation in drug disposition

  1979cited by this paper

• The Effect of Ecopipam on the Pharmacokinetics of Concomitant Medications

  2026cites this paper
• Navigating Drug–Drug Interactions in Clinical Drug Development: A Tutorial

  2025cites this paper
• Impact of Complex Genetic and Drug–Drug Interactions on Tamoxifen Metabolism and Efficacy

  2025cites this paper
• Quantitative Proteomics for Translational Pharmacology and Precision Medicine: State of The Art and Future Outlook

  2024cites this paper
• Safety Aspects of Herb Interactions: Current Understanding and Future Prospects.

  2024cites this paper
• Improving CYP2C19 phenotyping using stereoselective omeprazole and 5‐hydroxy‐omeprazole metabolic ratios

  2024cites this paper
• Phase 1 Studies to Assess Inhaled Seralutinib as a Perpetrator or a Victim of Drug‐Drug Interactions in Healthy Participants

  2024cites this paper
• Induction of cytochrome P450 via upregulation of CAR and PXR: a potential mechanism for altered florfenicol metabolism by macranthoidin B in vivo

  2024cites this paper
• Evaluation of the impact of vindoline, an active components of Catharanthus roseus, on rat hepatic cytochrome P450 enzymes by using a cocktail of probe drugs

  2023cites this paper
• Assessment of the drug–drug interaction potential for therapeutic proteins with pro‐inflammatory activities

  2023cites this paper
• Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs

  2023cites this paper
• Effect of liver disease on pharmacokinetics

  2022cites this paper
• Evaluation of a six-probe cocktail (caffeine, tolbutamide, omeprazole, dextromethorphan, midazolam, and digoxin) approach to estimate hepatic drug detoxification capability and dosage requirements after a single oral dosing in healthy Chinese volunteers

  2022cites this paper
• Prediction of the Area under the Curve Using Limited-Point Blood Sampling in a Cocktail Study to Assess Multiple CYP Activities.

  2021cites this paper
• Hepatic transporter‐mediated pharmacokinetic drug–drug interactions: Recent studies and regulatory recommendations

  2021cites this paper
• Verification of a cocktail approach for quantitative drug–drug interaction assessment: a comparative analysis between the results of a single drug and a cocktail drug

  2021cites this paper
• Sex Metabolic Differences and Effects on Blood Coagulation Among Rats Exposed to Sodium Dehydroacetate

  2021cites this paper
• Gut microbiota and host Cyp450s co-contribute to pharmacokinetic variability in mice with non-alcoholic steatohepatitis: Effects vary from drug to drug

  2021cites this paper
• Drug metabolism in severe chronic obstructive pulmonary disease: A phenotyping cocktail study

  2020cites this paper
• Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo

  2020cites this paper
• In vitro characterization and in vitro to in vivo predictions of drug-drug interactions

  2020cites this paper
• No Effect of Digoxin on Rosuvastatin Pharmacokinetics in Healthy Subjects: Utility of Oita Combination for Clinical Drug–Drug Interaction Study

  2019cites this paper
• Simultaneous phenotyping of CYP2E1 and CYP3A using oral chlorzoxazone and midazolam microdoses

  2019cites this paper
• Use of Cocktail Probe Drugs for Indexing Cytochrome P450 Enzymes in Clinical Pharmacology Studies - Review of Case Studies.

  2019cites this paper
• LC‐MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P‐glycoprotein probe substrates and their metabolites using subtherapeutic doses

  2019cites this paper
• Understanding the relevance of herb–drug interaction studies with special focus on interplays: a prerequisite for integrative medicine

  2019cites this paper
• Pharmacokinetics and phenotyping properties of the Basel phenotyping cocktail combination capsule in healthy male adults

  2019cites this paper
• Altered cytochrome 2E1 and 3A P450‐dependent drug metabolism in advanced ovarian cancer correlates to tumour‐associated inflammation

  2019cites this paper
• Repeated administration of Sailuotong, a fixed combination of Panax ginseng, Ginkgo biloba, and Crocus sativus extracts for vascular dementia, alters CYP450 activities in rats.

  2018cites this paper
• Evaluating the impact of type 2 diabetes mellitus on CYP450 metabolic activities: protocol for a case–control pharmacokinetic study

  2018cites this paper
• Polymorphism of CYP 2 D 6 , CYP 2 C 19 , CYP 2 C 9 and CYP 2 C 8 in the Faroese population

  2017cites this paper
• Therapeutic Protein Drug–Drug Interactions

  2017cites this paper
• In vivo Phenotyping Methods: Cytochrome P450 Probes with Emphasis on the Cocktail Approach.

  2017cites this paper
• Practical considerations when designing and conducting clinical pharmacokinetic herb–drug interaction studies

  2017cites this paper
• Lessons from Cuba for Global Precision Medicine: CYP2D6 Genotype Is Not a Robust Predictor of CYP2D6 Ultrarapid Metabolism

  2017cites this paper
• Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A

  2017cites this paper
• Drug metabolism and liver disease: a drug–gene–environment interaction

  2017influential citation
• Highly sensitive LC-MS/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in human.

  2017cites this paper
• Pre-absorption physicochemical compatibility assessment of 8-drug metabolic cocktail.

  2016cites this paper
• Simultaneous Determination of Cytochrome P450 Oxidation Capacity in Humans: A Review on the Phenotyping Cocktail Approach.

  2016cites this paper
• Effect of Omeprazole and Dextromethorphan on the Urinary Metabolic Ratio of Flurbiprofen.

  2016cites this paper
• Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers

  2016cites this paper
• Optimized Cocktail Phenotyping Study Protocol Using Physiological Based Pharmacokinetic Modeling and In silico Assessment of Metabolic Drug–Drug Interactions Involving Modafinil

  2016cites this paper
• Multiplex Phenotyping for Systems Medicine: A One-Point Optimized Practical Sampling Strategy for Simultaneous Estimation of CYP1A2, CYP2C9, CYP2C19, and CYP2D6 Activities Using a Cocktail Approach

  2016cites this paper
• Effect of fermented red ginseng on cytochrome P450 and P‐glycoprotein activity in healthy subjects, as evaluated using the cocktail approach

  2016cites this paper
• CombiCap: A novel drug formulation for the basel phenotyping cocktail.

  2016cites this paper
• Effect of Red Ginseng on cytochrome P450 and P-glycoprotein activities in healthy volunteers

  2015cites this paper
• The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical Setting-Proposal of a Four Component Transporter Cocktail.

  2015cites this paper
• Development, validation and application of the Basel phenotyping cocktail

  2015cites this paper
• The effect of single‐ and multiple‐dose etravirine on a drug cocktail of representative cytochrome P450 probes and digoxin in healthy subjects

  2014cites this paper
• The Basel Cocktail for Simultaneous Phenotyping of Human Cytochrome P450 Isoforms in Plasma, Saliva and Dried Blood Spots

  2014influential citation
• In Vivo Alterations in Drug Metabolism and Transport Pathways in Patients with Chronic Kidney Diseases

  2014cites this paper
• Present status and perspective of pharmacogenetics in Mexico

  2014cites this paper
• Актуальный обзор Актуальный обзор

  2014cites this paper
• The Use of Cytochrome P450 Phenotyping in Psychiatry

  2014cites this paper
• Evaluation on activity of cytochrome p450 enzymes in turbot via a probe drug cocktail.

  2014cites this paper
• Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma.

  2014cites this paper
• Pharmacokinetic of four probe drugs in adriamycin-induced nephropathy rat.

  2014cites this paper
• Effect of colchicine on rat hepatic cytochrome P450 enzymes by cocktail probe drugs.

  2014cites this paper
• Simultaneous LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 substrate drugs and their metabolites.

  2014cites this paper
• Validated Bioanalytical Method Development for the Determination of Alosetron in Human K2edta Plasma by Using LC-MS/MS

  2014cites this paper
• Simultaneous and comprehensive in vivo analysis of cytochrome P450 activity by using a cocktail approach in rats

  2014cites this paper
• Pharmacokinetic of four probe drugs in adriamycin-induced nephropathy rat.

  2014cites this paper
• A Response to the Letter of Iba on Liu et al., 2012. Effects of Panax notoginseng Saponins on the Activities of CYP1A2, CYP2C9, CYP2D6 and CYP3A4 in Rats In Vivo. Phytother Res 26: 1113–1118.

  2014cites this paper
• Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant Prescription.

  2014cites this paper
• Kava ichthyosis: a nitric oxide synthase inhibition?

  2013cites this paper
• Evaluation of drug-metabolizing enzyme hydroxylation phenotypes in Hispanic populations: the CEIBA cocktail

  2013cites this paper
• Original article / Article original Kava ichthyosis: a nitric oxide synthase inhibition? L'ichtyose due au kava : une inhibition des nitric oxyde synthases ?

  2013cites this paper
• Chronological Effects of Rifampicin Discontinuation on Cytochrome P450 Activity in Healthy Japanese Volunteers, Using the Cocktail Method

  2013cites this paper
• Intérêt des outils d’investigation des enzymes métaboliques en pratique clinique

  2013cites this paper
• Investigation tools for metabolic enzymes in clinical practice

  2013cites this paper
• THE EFFECT OF ENZYME INDUCTION AND ENZYME INHIBITION ON THE TOXICITY AND EFFICACY OF THE PRESCRIBED DRUGS-A REVIEW

  2013cites this paper
• Effect of Repeated Wuniu Early Tea Administration on the CYP450 Activity Using a Cocktail Method

  2013cites this paper
• Drug Cocktail Interaction Study on the Effect of the Orally Administered Lavender Oil Preparation Silexan on Cytochrome P450 Enzymes in Healthy Volunteers

  2013cites this paper
• Applications of CYP450 Testing in the Clinical Setting

  2013cites this paper
• DMD050203 987..993

  2013cites this paper
• Simultaneous in vivo phenotyping of CYP enzymes.

  2013cites this paper
• Effect of peginterferon alfa‐2a (40KD) on cytochrome P450 isoenzyme activity

  2013cites this paper
• Evaluation of impact of Herba Erigerontis injection, a Chinese herbal prescription, on rat hepatic cytochrome P450 enzymes by cocktail probe drugs.

  2012cites this paper
• Topics on Drug Metabolism

  2012cites this paper
• Effects of Ougan juice on P450 activities using a cocktail method.

  2012cites this paper
• Variation de sensibilité aux traitements psychotropes et origine génétique : à propos de huit cas de patients asiatiques

  2012cites this paper
• Paracetamol metabolism in postoperative patients

  2012influential citation
• Cocktail Approach for In Vivo Phenotyping of 5 Major CYP450 Isoenzymes: Development of an Effective Sampling, Extraction, and Analytical Procedure and Pilot Study With Comparative Genotyping

  2012cites this paper
• Quantifying four-probe metabolites in a single UPLC-MS/MS run to explore the effects of cooked rhubarb on cytochrome P450 isozymes.

  2012cites this paper
• Induction of cytochrome P450 enzymes: a view on human in vivo findings

  2012cites this paper
• Determination of Cytochrome P450 Metabolic Activity Using Selective Markers

  2012cites this paper
• High-sensitivity liquid chromatography-tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma.

  2012cites this paper
• HCV and Chemotherapy: Does Infection Change Management?

  2012cites this paper
• Analytical and pharmacological aspects of therapeutic drug monitoring of mTOR inhibitors.

  2011cites this paper
• Development of LC/MS techniques for plant and drug metabolism studies

  2011cites this paper
• FEXOFENADINE AND ORGANIC ANION TRANSPORTING POLYPEPTIDES (OATPs): TRANSPORT AND DRUG-DRUG INTERACTIONS

  2011cites this paper
• Drug Interaction Considerations Throughout Drug Development

  2011cites this paper
• Probe Cocktail Studies

  2011cites this paper
• A UPLC-MS/MS assay of the "Pittsburgh cocktail": six CYP probe-drug/metabolites from human plasma and urine using stable isotope dilution.

  2011cites this paper
• Effect of nicotine on cytochrome P450 1A2 activity.

  2011cites this paper
• Effects of multiple-dose pegylated interferon alfa-2b on the activity of drug-metabolizing enzymes in persons with chronic hepatitis C

  2011cites this paper
• Simultaneous HPLC determination of tolbutamide, phenacetin and their metabolites as markers of cytochromes 1A2 and 2C6/11 in rat liver perfusate.

  2010cites this paper
• UNIWERSYTET MEDYCZNY IM. KAROLA MARCINKOWSKIEGO W P OZNANIU KATEDRA I ZAKËAD FARMACJI KLINICZNEJ I BIOFARMACJI PRACOWNIA FARMAKOGENETYKI DOŚWIADCZALNEJ

  2010cites this paper
• Valorisation d'une plante traditionnelle océanienne : exemple du kava ( Piper methysticum Forst f.) : questions, éléments de réponses et perspectives

  2010cites this paper